Veradigm moves Jefferies investor chat to 3:35 CT
Veradigm adjusted the start time of its September 15, 2026 Jefferies conference fireside chat, keeping all other investor event plans unchanged.
Rhea-AI Filing Summary
Veradigm Inc. (MDRX) reported a scheduling change for its upcoming investor appearance at the 2026 Jefferies Healthcare Services and Technology Conference. The company’s fireside chat on September 15, 2026 in Nashville, Tennessee has been moved from 4:10 PM CT to 3:35 PM CT.
The change applies only to the Jefferies conference; previously announced details for Veradigm’s participation in the Deutsche Bank 2026 Healthcare Summit in New York, New York on September 16, 2026 remain the same. Veradigm stated that a live webcast of the Jefferies fireside chat will be available on its investor relations website.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Regulation FD regulatory
fireside chat financial
OTC Expert Market market
Inline XBRL technical
FAQ
What change did Veradigm Inc. (MDRX) announce regarding the 2026 Jefferies conference?
Does the Veradigm (MDRX) update affect its Deutsche Bank 2026 Healthcare Summit appearance?
When and where will Veradigm (MDRX) present at the 2026 Jefferies conference?
How can investors access Veradigm’s Jefferies conference presentation?
What securities of Veradigm Inc. (MDRX) are registered under Section 12(b)?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
As previously disclosed, on August 17, 2026, the Company announced that members of the Company's management would participate in the 2026 Jefferies Healthcare Services and Technology Conference in Nashville, Tennessee on September 15, 2026 and the Deutsche Bank 2026 Healthcare Summit in New York, New York on September 16, 2026.
On September 8, 2026, the Company issued a press release announcing an updated presentation time for the 2026 Jefferies Healthcare Services and Technology Conference. The Company's fireside chat, previously scheduled for 4:10 PM CT on September 15, 2026, will now take place at 3:35 PM CT on September 15, 2026. This update relates solely to the timing of the Company's presentation at the Jefferies conference and does not affect the previously announced details regarding the Deutsche Bank 2026 Healthcare Summit.
A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information furnished pursuant to this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit |
|
|
|
|
|
99.1 |
|
Press release issued by Veradigm Inc. on September 8, 2026 |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
VERADIGM INC. |
|
|
|
|
Date: |
September 8, 2026 |
By: |
/s/ Eric Jacobson |
|
|
|
Eric Jacobson |
Exh. 99.1
Veradigm Announces Updated Presentation Time for Upcoming Investor Conference
September 08, 2026
CHICAGO--(BUSINESS WIRE)—September 8, 2026 -- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that it will now present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15th at 3:35PM CT. A live webcast of the fireside chat will be available at the Veradigm investor relations website.
About Veradigm®
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system.
© 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.
For more information contact:
Investors:
Steven Halper
312-506-1237
steven.halper@veradigm.com
Media:
Katie Wilson 601-398-7000
katie.wilson@veradigm.com
Source: Veradigm